Acadian Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-78,218
| Closed | -$197K | – | 2474 |
|
|
2020
Q2 | $197K | Buy |
+78,218
| New | +$197K | ﹤0.01% | 1496 |
|
|
2020
Q1 | – | Sell |
-671
| Closed | -$2K | – | 2018 |
|
|
2019
Q4 | $2K | Sell |
671
-6,137
| -90% | -$18.3K | ﹤0.01% | 1804 |
|
|
2019
Q3 | $37K | Sell |
6,808
-19,187
| -74% | -$104K | ﹤0.01% | 1655 |
|
|
2019
Q2 | $250K | Sell |
25,995
-2,016
| -7% | -$19.4K | ﹤0.01% | 1176 |
|
|
2019
Q1 | $750K | Buy |
28,011
+8,747
| +45% | +$234K | ﹤0.01% | 995 |
|
|
2018
Q4 | $436K | Sell |
19,264
-2,410
| -11% | -$54.5K | ﹤0.01% | 938 |
|
|
2018
Q3 | $1.2M | Buy |
21,674
+19,585
| +938% | +$1.08M | ﹤0.01% | 680 |
|
|
2018
Q2 | $149K | Sell |
2,089
-6,106
| -75% | -$436K | ﹤0.01% | 1150 |
|
|
2018
Q1 | $503K | Buy |
+8,195
| New | +$503K | ﹤0.01% | 861 |
|
|
2017
Q3 | – | Sell |
-6,359
| Closed | -$907K | – | 1610 |
|
|
2017
Q2 | $907K | Sell |
6,359
-12,593
| -66% | -$1.8M | ﹤0.01% | 725 |
|
|
2017
Q1 | $3.48M | Buy |
18,952
+9,851
| +108% | +$1.81M | 0.02% | 489 |
|
|
2016
Q4 | $734K | Buy |
9,101
+7,059
| +346% | +$569K | ﹤0.01% | 780 |
|
|
2016
Q3 | $157K | Sell |
2,042
-957
| -32% | -$73.6K | ﹤0.01% | 1001 |
|
|
2016
Q2 | $257K | Buy |
+2,999
| New | +$257K | ﹤0.01% | 881 |
|